Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2011 February;59(1) > Minerva Cardioangiologica 2011 February;59(1):109-12

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

CASE REPORTS   

Minerva Cardioangiologica 2011 February;59(1):109-12

Copyright © 2011 EDIZIONI MINERVA MEDICA

language: English

Evaluation of re-endothelization extent at mid-term follow-up after drug eluting balloon plus bare metal stent implantation during primary coronary angioplasty: insight from OCT imaging

Rollini F., Aprile A., Politi L., Sangiorgi G. M.

Department of Cardiology, Interventional Cardiology Unit, University of Modena and Reggio Emilia, Modena, Italy


PDF


One quarter of patients with STEMI submitted to primary percutaneous coronary intervention (PCI) need repeated target vessel revascularization (TVR) because of stent restenosis or thrombosis. Introduction of DES has effectively reduced the incidence of these complications but the safety of this type of stent in the setting of AMI is limited due to the unpredictable risk of stent malapposition and vessel remodelling in the long term follow-up. Recently, treatment with drug eluting balloon (DEB) in association with bare metal stenting (BMS) has been reported to have an excellent efficacy and safety profile. However, little is known regarding the extent of stent coverage in BMS after DEB utilization.

top of page